Glypican-3 (GPC3) is a cell-surface heparan sulfate proteoglycan overexpressed in hepatocellular carcinoma, with minimal expression in normal adult liver. GPC3 is a clinically pursued target for HCC CAR-T and antibody therapy.
| Catalog No. | Product Name | Conjugate | Size | Price (In USD) |
|---|---|---|---|---|
| GM-Tg-hg-T25726-Ab-3-PE | Anti-Human GPC3/Glypican 3 monoclonal antibody(mAb)(PE) | PE | 25T | |
| GM-Tg-hg-T25726-Ab-3-PE | Anti-Human GPC3/Glypican 3 monoclonal antibody(mAb)(PE) | PE | 100T | |
| GM-Tg-hg-T25726-Ab-3-PE | Anti-Human GPC3/Glypican 3 monoclonal antibody(mAb)(PE) | PE | 500T | |
| GM-Tg-hg-T25726-Ab-3-FITC | Anti-Human GPC3/Glypican 3 monoclonal antibody(mAb)(FITC) | FITC | 25T | |
| GM-Tg-hg-T25726-Ab-3-FITC | Anti-Human GPC3/Glypican 3 monoclonal antibody(mAb)(FITC) | FITC | 100T | |
| GM-Tg-hg-T25726-Ab-3-FITC | Anti-Human GPC3/Glypican 3 monoclonal antibody(mAb)(FITC) | FITC | 500T | |
| GM-Tg-hg-T25726-Ab-3-APC | Anti-Human GPC3/Glypican 3 monoclonal antibody(mAb)(APC) | APC | 25T | |
| GM-Tg-hg-T25726-Ab-3-APC | Anti-Human GPC3/Glypican 3 monoclonal antibody(mAb)(APC) | APC | 100T | |
| GM-Tg-hg-T25726-Ab-3-APC | Anti-Human GPC3/Glypican 3 monoclonal antibody(mAb)(APC) | APC | 500T | |
| GM-Tg-hg-T25726-Ab-3-Biotin | Anti-Human GPC3/Glypican 3 monoclonal antibody(mAb)(Biotin) | Biotin | 25T, 100T, 500T |
| Target | GPC3 (specific biomarker for human hepatocellular carcinoma cell) |
|---|---|
| Species | Humanized |
| Expression platform | Mammalian cell |
| Isotypes | Human IgG |
| Tag | hFc |
| Conjugate | PE / FITC / APC / Biotin |
| Size | 25T / 100T / 500T |
| Purity | >=95% (SDS-PAGE) |
| Bioactivity validation | GPC3 binding, FACS in GPC3 level test |
| Application | FACS and other Immunoassay for GPC3 test |
| Products description | Anti-Human GPC3/Glypican 3 monoclonal antibody(mAb)(PE/FITC/APC/Biotin) is a recombinant monoclonal antibody. It specifically recognizes GPC3 (glypican-3, a heparan sulfate proteoglycan over-expressed in HCC). GPC3 is a hepatocellular carcinoma cell marker. This antibody is validated by FACS for solid-tumor target assessment for GPC3 CAR-T. It is recommended for multi-color flow cytometry panels to validate GPC3 expression for hepatocellular-carcinoma CAR-T screening in CAR-T cell therapy manufacturing, QC and functional assessment. |
| Formulation & Reconstitution | Lyophilized from sterile PBS, pH 7.4 |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |